Literature DB >> 16266693

Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates.

Andrew C Newby1.   

Abstract

Intimal thickening occurs in blood vessels in response to injury or atherosclerosis. The balance of migration and proliferation of vascular smooth muscle cells (VSMC) over death by apoptosis has an important impact on the final size of intimal thickening and may also affect atherosclerotic plaque stability. All aspects of VSMC behaviour are under coordinated control by growth factors, cell-matrix and cell-cell interactions. We review the evidence that matrix-degrading metalloproteinases (MMPs) regulate migration, proliferation and survival of VSMC. Moreover, we discuss critically the underlying mechanisms, which include changing growth factor availability and remodelling cell-matrix and cell-cell contacts. We conclude that MMPs influence VSMC behaviour by cleaving both matrix and non-matrix substrates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16266693     DOI: 10.1016/j.cardiores.2005.08.002

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  166 in total

1.  Active leukocyte detachment and apoptosis/necrosis on PEG hydrogels and the implication in the host inflammatory response.

Authors:  Heather Waldeck; Xintong Wang; Evan Joyce; Weiyuan John Kao
Journal:  Biomaterials       Date:  2011-10-02       Impact factor: 12.479

2.  Pressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosis.

Authors:  Michael R Zile; Catalin F Baicu; Robert E Stroud; An Van Laer; Jazmine Arroyo; Rupak Mukherjee; Jeffrey A Jones; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-27       Impact factor: 4.733

3.  Interstitial flow promotes vascular fibroblast, myofibroblast, and smooth muscle cell motility in 3-D collagen I via upregulation of MMP-1.

Authors:  Zhong-Dong Shi; Xin-Ying Ji; Henry Qazi; John M Tarbell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-22       Impact factor: 4.733

Review 4.  Patient-specific modeling of cardiovascular mechanics.

Authors:  C A Taylor; C A Figueroa
Journal:  Annu Rev Biomed Eng       Date:  2009       Impact factor: 9.590

Review 5.  Mechanisms of arterial remodeling in hypertension: coupled roles of wall shear and intramural stress.

Authors:  Jay D Humphrey
Journal:  Hypertension       Date:  2008-06-09       Impact factor: 10.190

6.  Non-random distribution and sensory functions of primary cilia in vascular smooth muscle cells.

Authors:  C J Lu; H Du; J Wu; D A Jansen; K L Jordan; N Xu; G C Sieck; Q Qian
Journal:  Kidney Blood Press Res       Date:  2008-05-16       Impact factor: 2.687

7.  Rice bran protein hydrolysates reduce arterial stiffening, vascular remodeling and oxidative stress in rats fed a high-carbohydrate and high-fat diet.

Authors:  Ketmanee Senaphan; Weerapon Sangartit; Poungrat Pakdeechote; Veerapol Kukongviriyapan; Patchareewan Pannangpetch; Supawan Thawornchinsombut; Stephen E Greenwald; Upa Kukongviriyapan
Journal:  Eur J Nutr       Date:  2016-09-22       Impact factor: 5.614

8.  Ribosomal protein L13a deficiency in macrophages promotes atherosclerosis by limiting translation control-dependent retardation of inflammation.

Authors:  Abhijit Basu; Darshana Poddar; Peggy Robinet; Jonathan D Smith; Maria Febbraio; William M Baldwin; Barsanjit Mazumder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-01-16       Impact factor: 8.311

9.  p-Cresyl sulfate promotes the formation of atherosclerotic lesions and induces plaque instability by targeting vascular smooth muscle cells.

Authors:  Hui Han; Yanjia Chen; Zhengbin Zhu; Xiuxiu Su; Jingwei Ni; Run Du; Ruiyan Zhang; Wei Jin
Journal:  Front Med       Date:  2016-09-07       Impact factor: 4.592

Review 10.  Caldesmon as a therapeutic target for proliferative vascular diseases.

Authors:  Chi-Ming Hai
Journal:  Mini Rev Med Chem       Date:  2008-10       Impact factor: 3.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.